3D structure of human clusterin sheds light on Alzheimer's risk factor Updated on: October 01,2025 3D structure of human clusterin sheds light on Alzheimer's risk factor Updated on:October 01,2025
Inhibiting an astrocytic 'brake' that blocks spinal cord repair could pave path to neuronal regeneration Updated on: October 02,2025 Inhibiting an astrocytic 'brake' that blocks spinal cord repair could pave path to neuronal regeneration Updated on:October 02,2025
Scientists identify novel therapeutic target for ovarian cancer Updated on: October 02,2025 Scientists identify novel therapeutic target for ovarian cancer Updated on:October 02,2025
Misconceptions keep some cancer patient populations from benefiting from hormone therapy, survey reveals Updated on: October 02,2025 Misconceptions keep some cancer patient populations from benefiting from hormone therapy, survey reveals Updated on:October 02,2025
Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC, trial shows Updated on: October 02,2025 Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC, trial shows Updated on:October 02,2025
BMS-986504 demonstrates durable responses in MTAP-deleted NSCLC, including EGFR and ALK-positive tumors Updated on: October 02,2025 BMS-986504 demonstrates durable responses in MTAP-deleted NSCLC, including EGFR and ALK-positive tumors Updated on:October 02,2025
Smoking status should influence lung cancer staging, new study shows Updated on: October 02,2025 Smoking status should influence lung cancer staging, new study shows Updated on:October 02,2025
Lung cancer rewires immune cells in bone marrow to weaken body's defenses Updated on: October 02,2025 Lung cancer rewires immune cells in bone marrow to weaken body's defenses Updated on:October 02,2025
GLP-1 receptor agonists may improve lung cancer outcomes Updated on: October 02,2025 GLP-1 receptor agonists may improve lung cancer outcomes Updated on:October 02,2025
New research identifies IFITM3 as key driver of immunotherapy response in small cell lung cancer Updated on: October 02,2025 New research identifies IFITM3 as key driver of immunotherapy response in small cell lung cancer Updated on:October 02,2025